期刊文献+

社区卫生服务中心管理窗口模式管理心房颤动患者效果分析 被引量:2

Management window for patients with atrial fibrillation in community health center
原文传递
导出
摘要 建立心房颤动(房颤)管理窗口,筛查在本社区卫生服务中心就诊的房颤患者并纳入管理,采用综合治疗管理方案和流程对患者进行治疗管理和随访。结果有效管理房颤患者105例(97.2%),平均管理随访10.6个月;CHADS:评分≥2分78例,其中服用华法林11例,占14.1%;26例阵发性房颤无一例转变为持续性房颤。与管理前比较,房颤患者管理后服用阿司匹林和华法林比率均提高(均P〈0.05),口服华法林患者INR达标率提高(P〈0.05);纳入管理的患者均接受综合诊疗方案、规范治疗和健康教育,较管理前明显好转(均P〈0.05);患者对疾病认识、治疗的依从性和满意度均明显提高(均P〈0.05)。提示社区卫生服务中心以房颤管理窗口模式对房颤患者进行治疗管理,对减少房颤复发,提高华法林使用率,提高患者合理治疗的依从性是可行有效的。 A management window model for patients with atrial fibrillation (AF) was established in Tilanqiao Community Health Service Center cooperated with tertiary hospitals. Patients were screened and treated in the community health service center, and a comprehensive management plan was conducted and patients were followed-up. A total of 105 patients with atrial fibrillation (97. 2% ) were effectively managed with an average follow-up of 10. 6 months. The CHADS2 score /〉 2 in 78 cases, including 11 cases with administration of warfarin ( 14. 1% ) and 26 cases with paroxysmal AF without transition to persistent atrial fibrillation. Compared to the data before management, the rate of taking aspirin and warfarin in managed patients was increased ( all P 〈 0. 05 ), the international normalized ratio ( INR ) of patients receiving warfarin was improved ( P 〈 0. 05 ) ; the ratio of receiving comprehensive treatment program, standardized treatment and health education were significantly increased ( P 〈 0. 05 ) ; the awareness of the disease, treatment compliance and satisfaction of patients were improved significantly ( all P 〈 0. 05 ). The results suggest that the management widow model is feasible and effective for management of patients with atrial fibrillation in community health service centers.
出处 《中华全科医师杂志》 2013年第6期463-465,共3页 Chinese Journal of General Practitioners
基金 上海市虹口区科学委员会立项课题,上海市虹口区卫生局重点课题资助项目(虹卫1102-14)
关键词 心房颤动 疾病管理 Atrial fibrillation Disease management
  • 相关文献

参考文献11

  • 1胡大一,孙艺红,周自强,李奎宝,倪永斌,杨光,孙淑红,李蕾.中国人非瓣膜性心房颤动脑卒中危险因素的病例-对照研究[J].中华内科杂志,2003,42(3):157-161. 被引量:361
  • 2周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1401
  • 3黄从新,马长生,杨延宗,黄德嘉,张澍,江洪,杨新春,吴书林,马坚,刘少稳,李莉,曹克将,王方正,陈新.心房颤动:目前的认识和治疗建议(二)[J].中华心律失常学杂志,2006,10(3):167-197. 被引量:269
  • 4European Heart Rhythm Association,European Association forCardio-Thoracic Surgery,Camm AJ,et al. Guidelines for themanagement of atrial fibrillation:The Task Force for theManagement of Atrial Fibrillation of the European Society ofCardiology (ESC). Eur Heart J,2010,31 :2369-2429.
  • 5Wann LS,Curtis AB,January CT,et al. 2011 ACCF/AHA/HRSfocused update on the management of patients with atrialfibrillation(updating the 2006guideline) :a report of the AmericanCollege of Cardiology Foundation/American Heart Association TaskForceon Practice Guidelines. Circulation,2011 ,123:104-123.
  • 6Stewart S,Hart CL,Hole DJ,et al. Population prevalence,incidence,and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart,2001,86:516-521.
  • 7de Vos CB,Pisters R,Nieuwlaat R,et al. Progression fromparoxysmal to persistent atrial fibrillation clinical correlates andprognosis. J Am Coll Cardiol,2010,55:725-731.
  • 8Hart RG,Pearce LA. Current status of stroke risk stratification inpatients with atrial fibrillation. Stroke ,2009,40:2607-2610.
  • 9心房颤动抗凝治疗中国专家共识[J].中华内科杂志,2012,51(11):916-921. 被引量:139
  • 10马长生.心房颤动抗凝治疗之六大争议解析[J].中华医学信息导报,2012,27(15):13-14. 被引量:1

二级参考文献21

共引文献1946

同被引文献28

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部